Back to Search
SAIRA AGARWALA, MD
MD
Dermatology Physician
NPI: 1760062228IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD487901(PA)
CMS Specialties
PrimaryDERMATOLOGY
Education
OTHER
Class of 2021
Research & Publications (20)
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008.
PMID 19659612·Pigment Cell Melanoma Res·2009
8-other
Current systemic therapy for metastatic melanoma.
PMID 19445576·Expert Rev Anticancer Ther·2009
6-review
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).
PMID 19419855·Eur J Cancer·2009
4-observational
Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer.
PMID 17675395·Ann Oncol·2007
3-trial
Double valve replacement for acute spontaneous left chordal rupture secondary to chronic aortic incompetence.
PMID 17026749·J Cardiothorac Surg·2006
5-case
Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver.
PMID 15179192·Melanoma Res·2004
3-trial
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
PMID 15169796·J Clin Oncol·2004
3-trial
Effect of chlorpyrifos on efflux transporter gene expression and function in Caco-2 cells.
PMID 15130596·Toxicol In Vitro·2004
8-other
Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
PMID 15073858·Cancer·2004
3-trial
Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
PMID 12491513·Cancer·2003
3-trial
Evaluation of renal function in transplant patients on tacrolimus therapy.
PMID 12092747·J Clin Pharmacol·2002
3-trial
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
PMID 11773161·J Clin Oncol·2002
3-trial
Chemotherapy Foundation Symposium XVIII: Session on malignant melanoma.
PMID 11424886·Expert Opin Investig Drugs·2001
8-other
Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood.
PMID 11475121·Eur J Pediatr Surg·2001
5-case
Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment.
PMID 11728221·Expert Opin Biol Ther·2001
6-review
Sonic hedgehog control of size and shape in midbrain pattern formation.
PMID 11251119·Science·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 801 OSTRUM ST
BETHLEHEM, PA 18015 - Phone
- (484) 526-0433
Quick Facts
- NPI
- 1760062228
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile